What iTeos Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Gall Matthew | Chief Financial Officer | Aug 29 | Tender Offer · U | −89,429 | — | — | 0 |
| McGrath Yvonne | Chief Scientific Officer | Aug 29 | Tender Offer · U | −46,300 | — | — | 0 |
| Feltquate David | Chief Medical Officer | Aug 29 | Tender Offer · U | −47,000 | — | — | 0 |
| Detheux Michel | Chief Executive Officer | Aug 29 | Tender Offer · U | −94,027 | — | — | 0 |
| Detheux Michel | Chief Executive Officer | Aug 29 | Tender Offer · U | −153,903 | — | — | 0 |
| Call Matthew | Chief Operating Officer | Aug 29 | Tender Offer · U | −161,898 | — | — | 0 |
| Detheux Michel | Chief Executive Officer | Jun 10 | Exercise / conversion · M | +94,027 | $4.30 | +$404K | 94,027 |
| Detheux Michel | Chief Executive Officer | Jun 10 | Exercise / conversion · M | +18,000 | $4.30 | +$77.4K | 153,903 |
| Detheux Michel | Chief Executive Officer | Jun 10 | Open-market sale · S | −43,883 | $10.02 | −$440K | 0 |
| Detheux Michel | Chief Executive Officer | Jun 10 | Exercise / conversion · M | +43,883 | $4.30 | +$189K | 43,883 |
| Detheux Michel | Chief Executive Officer | Jun 10 | Open-market sale · S | −8,400 | $10.02 | −$84.2K | 135,903 |
| Detheux Michel | Chief Executive Officer | Jun 10 | Exercise / conversion · M | +8,400 | $4.30 | +$36.1K | 144,303 |
| Detheux Michel | Chief Executive Officer | Jun 09 | Open-market sale · S | −43,882 | $10.03 | −$440K | 0 |
| Detheux Michel | Chief Executive Officer | Jun 09 | Exercise / conversion · M | +43,882 | $4.30 | +$189K | 43,882 |
| Detheux Michel | Chief Executive Officer | Jun 09 | Open-market sale · S | −8,400 | $10.03 | −$84.3K | 135,903 |
| Detheux Michel | Chief Executive Officer | Jun 09 | Exercise / conversion · M | +8,400 | $4.30 | +$36.1K | 144,303 |
| Hallal David | Director | Jun 06 | Open-market sale · S | −38,228 | $10.24 | −$391K | 0 |
| Hallal David | Director | Jun 06 | Exercise / conversion · M | +38,228 | $4.30 | +$164K | 38,228 |
| Detheux Michel | Chief Executive Officer | Jun 06 | Open-market sale · S | −43,882 | $10.21 | −$448K | 0 |
| Detheux Michel | Chief Executive Officer | Jun 06 | Exercise / conversion · M | +43,882 | $4.30 | +$189K | 43,882 |
Loading...
